Genetic and Pharmacological Disruption of Neurokinin 1 Receptor Function Decreases Anxiety-Related B...
Genetic and Pharmacological Disruption of Neurokinin 1 Receptor Function Decreases Anxiety-Related Behaviors and Increases Serotonergic Function
About this item
Full title
Author / Creator
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Alterations in serotonin (5-hydroxytriptamine, 5-HT), norepinephrine, and γ-aminobutyric acid have been linked to the pathophysiology of anxiety and depression, and medications that modulate these neurotransmitters are widely used to treat mood disorders. Recently, the neuropeptide substance P (SP) and its receptor, the neurokinin 1 receptor (NK1R)...
Alternative Titles
Full title
Genetic and Pharmacological Disruption of Neurokinin 1 Receptor Function Decreases Anxiety-Related Behaviors and Increases Serotonergic Function
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_17756868
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17756868
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.041596398
